CLEAR PROOF ACNE TREATMENT ACNE MEDICATION- benzoyl peroxide gel 
Mary Kay Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Clear Proof Acne Treatment Gel

Drug Facts

Active ingredient:

Benzoyl Peroxide 5%

Purpose

Acne Medication

Uses

Warnings

For external use only.

Do not use if you

  • have very sensitive skin
  • are sensitive to benzoyl peroxide

When using this product

  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
  • avoid unnecessary sun exposure and use a sunscreen
  • avoid contact with the eyes, lips and mouth
  • avoid contact with hair and dyed fabrics, which may be bleached by this product
  • skin irritation may occur, characterized by redness, burning, itching, peeling or possibly swelling. Irritation may be reduced by using the product less frequently or in a lower concentration.

Stop use and ask a doctor if

irritation becomes severe

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other information

Inactive ingredients

aesculus hippocastanum (horse chestnut) seed extract, butylene glycol, carbomer, cucumis sativus (cucumber) fruit extract, diethylhexyl sodium sulfosuccinate, disodium EDTA, echinacea purpurea extract, glycerin, poloxamer 182, propylene glycol, silica, sodium hydroxide, water

Principal Display Panel - 28 g carton

clearproof

acne treatment gel

acne medication
5% benzoyl peroxide

1 OZ. NET WT./28 g

Mary Kay

image of carton

CLEAR PROOF ACNE TREATMENT  ACNE MEDICATION
benzoyl peroxide gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51531-9071
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BENZOYL PEROXIDE (UNII: W9WZN9A0GM) (BENZOYL PEROXIDE - UNII:W9WZN9A0GM) BENZOYL PEROXIDE5 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
POLOXAMER 182 (UNII: JX0HIX6OAG)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) (UNII: 4Q93RCW27E)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
DOCUSATE SODIUM (UNII: F05Q2T2JA0)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
GLYCERIN (UNII: PDC6A3C0OX)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
ECHINACEA PURPUREA (UNII: QI7G114Y98)  
CUCUMBER (UNII: YY7C30VXJT)  
HORSE CHESTNUT (UNII: 3C18L6RJAZ)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:51531-9071-11 in 1 CARTON08/16/2016
128 g in 1 TUBE; Type 0: Not a Combination Product
2NDC:51531-9071-03 g in 1 TUBE; Type 0: Not a Combination Product08/16/2016
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalM00606/15/2012
Labeler - Mary Kay Inc. (049994452)
Establishment
NameAddressID/FEIBusiness Operations
Port Jervis Laboratories Inc.001535103manufacture(51531-9071)

Revised: 9/2022
Document Id: e959da7c-3755-681e-e053-2a95a90abcd3
Set id: e01859b1-057e-4b01-8b37-2df378aae212
Version: 6
Effective Time: 20220923
 
Mary Kay Inc.